Contribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in Cameroon

Journal of Diabetes and Metabolic Disorders

Volumn 14, Issue 1, 2015, Pages

  Guewo Fokeng, Magellan ^a   Sobngwi, Eugene ^a   Atogho Tiedeu, Barbara ^a   Donfack, Olivier S ^a   Noubiap, Jean J N ^b,c   Ngwa, Elvis N ^a   Mato Mofo, Edith P ^a   Fosso, Priscille P ^a   Djahmeni, Eric ^a   Djokam Dadjeu, Rosine ^a   Evehe, Marie Solange ^a   Aminkeng, Folefac ^d   Mbacham, Wilfred F ^a   Mbanya, Jean C ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Serology Unit   (Cameroon)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cameroon; Genetic association; Sub Saharan Africa; Transcription factor 7 like 2 (TCF7L2); Type 2 diabetes

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CAMEROONIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; TCF7L2 GENE;

EID: 84927738356     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/s40200-015-0148-z     Document Type: Article

References (27)

1. Guillausseau PJ, Meas T, Virally M, Laloi-Michelin M, Médeau V, Kevorkian JP. Abnormalities in insulin secretion in type 2 diabetes mellitus. Diabetes Metab 2008, 34(Suppl 2):S43-8. 10.1016/S1262-3636(08)73394-9, 18640585.
2. Seshasai SRK, Kaptoge S, Thompson A, Di Angekantinio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011, 364(9):829-841. 10.1056/NEJMoa1008862, 21366474.
3. International Diabetes Federation: IDF Diabetes Atlas. 6th ed. Brussels, 2013. Available at: http://www.idf.org/diabetesatlas. Accessed: September 30, 2014..
4. McCarthy MI, Froguel P. Genetic approaches to the molecular understanding of type 2 diabetes. Am J Physiol Endocrinol Metab 2002, 283(2):E217-225. 10.1152/ajpendo.00099.2002, 12110525.
5. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445(7130):881-885. 10.1038/nature05616, 17293876.
6. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38(3):320-323. 10.1038/ng1732, 16415884.
7. Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, Sjogren M, et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in non-diabetic individuals. Diabetes 2006, 55(10):2890-2895. 10.2337/db06-0381, 17003358.
8. Reynisdottir I, Thorleifsson G, Benediktsson R, Sigurdsson G, Emilsson V, Einarsdottir AS, et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am J Hum Genet 2003, 73(2):323-335. 10.1086/377139, 12851856.
9. Groves CJ, Zeggini E, Minton J, Frayling TM, Weedon MN, Rayner NW, et al. Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 2006, 55:2640-2644. 10.2337/db06-0355, 16936215.
10. Zhang C, Qi L, Hunter DJ, Manson JE, van Dam RM, Hu FB, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men. Diabetes 2006, 55(9):2645-2648. 10.2337/db06-0643, 16936216.
11. Scott LJ, Bonnycastle LL, Willer CJ, Sprau AG, Jackson AU, Narisu N, et al. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 2006, 55(9):2649-2653. 10.2337/db06-0341, 16936217.
12. Damcott CM, Pollin TI, Reinhart LJ, Ott S, Shen H, Silver KD, et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006, 55(9):2654-2659. 10.2337/db06-0338, 16936218.
13. Cauchi S, Meyre D, Dina C, Choquet H, Samson C, Gallina S, et al. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006, 55(10):2903-2908. 10.2337/db06-0474, 17003360.
14. Ostaptchouk JV, Sverdlov RS, Zhernakova A, Strengman E, van Haeften TW, Hofker MH, et al. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort. Diabetologia 2007, 50(1):59-62. 10.1007/s00125-006-0477-z.
15. Humphries SE, Gable D, Cooper JA, Ireland H, Stephens JW, Hurel SJ, et al. Common variants in theTCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. J Mol Med 2006, 84(12):1-10. 10.1007/s00109-006-0108-7.
16. Mayans S, Lackovic K, Lindgren P, Ruihha K, Agren A, Eliasson M, et al. TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden. Eur J Hum Genet 2007, 15(3):342-346. 10.1038/sj.ejhg.5201773, 17245407.
17. Horikoshi M, Hara K, Ito C, Nagai R, Froguel P, Kadowaki T. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. Diabetologia 2007, 50(4):747-751. 10.1007/s00125-006-0588-6, 17245589.
18. Danguah I, Othmer T, Frank LK, Bedu-Addo G, Schulze MB, Mockenhaupt FP. The TCF7L2 rs7903146 (T) allele is associated with type 2 diabetes in urban Ghana: a hospital-based case-control study. BMC Med Genet 2013, 14:96. 10.1186/1471-2350-14-96.
19. Mtiraoui N, Turki A, Nemr R, Echtay A, Izzidi I, Al-Zaben GS, et al. Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARγ, SLC20A8 and TCFL2 to the risk of type 2 diabetes in Lebanese and Tunisians Arabs. Diabetes Metab 2012, 38(5):444-449. 10.1016/j.diabet.2012.05.002, 22749234.
20. Berhouma R, Kouidhi S, Ammar M, Abid H, Barouti T, Ennafaa H, et al. Genetic susceptibility to type 2 diabetes: a global meta-analysis studying the genetic differences in Tunisian populations. Hum Biol 2012, 84(4):423-35. 10.3378/027.084.0405, 23249316.
21. Tong Y, Lin Y, Zhang Y, Yang J, Zhang Y, Liu H. Association between TCFL2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 2009, 10:15. 10.1186/1471-2350-10-15, 19228405.
22. Staiger H, Machicao F, Fritsche A, Haring HU. Pathomechanisms of type 2 diabetes genes. Endocr Rev 2009, 30(6):557-585. 10.1210/er.2009-0017, 19749172.
23. WHO-IDF. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Available at: http://www.idf.org/webdata/docs/WHO_IDF_definition_diagnosis_of_diabetes.pdf. Accessed: October 1, 2014..
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of low density lipoprotein cholesterol without the use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502. 4337382.
25. Gauderman WJ, Morrison JM. Quanto: A computer program for power and sample size calculations for genetic-epidemiology studies; 2006. Available at: http://biostats.usc.edu/software. Accessed: October 1, 2014..
26. Research capacity. Enabling the genomic revolution in Africa. Science 2014, 344(6190):1346-8. 10.1126/science.1251546.
27. Guinan KJ. Worldwide distribution of type II diabetes-associated TCF7L2 SNPs: evidence for stratification in Europe. Biochem Genet 2012, 50(3-4):159-179. 10.1007/s10528-011-9456-2, 21898192.